Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About MCB
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Molecular and Cellular Biology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About MCB
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Articles

Rho2 Palmitoylation Is Required for Plasma Membrane Localization and Proper Signaling to the Fission Yeast Cell Integrity Mitogen-Activated Protein Kinase Pathway

Laura Sánchez-Mir, Alejandro Franco, Rebeca Martín-García, Marisa Madrid, Jero Vicente-Soler, Teresa Soto, Mariano Gacto, Pilar Pérez, José Cansado
Laura Sánchez-Mir
aYeast Physiology Group, Department of Genetics and Microbiology, Facultad de Biología, Universidad de Murcia, Murcia, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alejandro Franco
aYeast Physiology Group, Department of Genetics and Microbiology, Facultad de Biología, Universidad de Murcia, Murcia, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rebeca Martín-García
bInstituto de Biología Funcional y Genómica, Consejo Superior de Investigaciones Científicas/Departamento de Microbiología y Genética, Universidad de Salamanca, Salamanca, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marisa Madrid
aYeast Physiology Group, Department of Genetics and Microbiology, Facultad de Biología, Universidad de Murcia, Murcia, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jero Vicente-Soler
aYeast Physiology Group, Department of Genetics and Microbiology, Facultad de Biología, Universidad de Murcia, Murcia, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Teresa Soto
aYeast Physiology Group, Department of Genetics and Microbiology, Facultad de Biología, Universidad de Murcia, Murcia, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mariano Gacto
aYeast Physiology Group, Department of Genetics and Microbiology, Facultad de Biología, Universidad de Murcia, Murcia, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pilar Pérez
bInstituto de Biología Funcional y Genómica, Consejo Superior de Investigaciones Científicas/Departamento de Microbiología y Genética, Universidad de Salamanca, Salamanca, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
José Cansado
aYeast Physiology Group, Department of Genetics and Microbiology, Facultad de Biología, Universidad de Murcia, Murcia, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/MCB.01515-13
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Additional Files
  • FIG 1
    • Open in new tab
    • Download powerpoint
    FIG 1

    Rho2 is palmitoylated in vivo. (A) C-terminal sequences of Rho2 constructs employed include a single HA tag followed by the KSSTKCCIIS motif (control) and mutated versions in which cysteine-196 (SCIIS), cysteine-197 (CSIIS), or both residues (SSIIS) were replaced by serine. (B) Conserved C-terminal sequences in selected human RhoB family small GTPases and Rho GTPases from budding and fission yeasts. Positively charged residues are underlined. Prenylated cysteine residues (F, farnesylation; GG, geranylgeranylation) are in boldface, whereas palmitoylatable cysteines (P, palmitoylation) are in boldface and italics. H. sapiens, Homo sapiens. (C) Strain LSM400 (Rho2-HA-CCIIS) was grown in YES medium to mid-log phase in the absence or presence of 100 μM 2-bromopalmitate (2-BP) for 3 h and treated with 0.6 M KCl. Aliquots were harvested at timed intervals, and activated and total Pmk1s were detected with anti-phospho-p44/42 and anti-HA antibodies, respectively. R.U, relative units. (D) Rho2 palmitoylation assayed by the acyl-biotinyl switch assay (upper blot) in cell lysates from strains LSM400 (Rho2-HA-CCIIS, control), LSM401 (Rho2-HA-SCIIS), LSM402 (Rho2-HA-CSIIS), and LSM403 (Rho2-HA-SSIIS). Biotinylation is specific for proteins containing a free sulfhydryl generated after hydroxylamine cleavage of a thioester bond, indicating palmitoylation. Total extracts from the strains were included as controls (lower blot). Rho2 was detected by employing anti-HA antibody. (E) SDS-PAGE of cell lysates from strains described for panel D. Pmk1 and Rho2 were detected by immunoblotting with anti-HA antibody, and Rho2 levels were quantified using Pmk1 as an internal control. *, P < 0.05 in mutant strains compared to the control.

  • FIG 2
    • Open in new tab
    • Download powerpoint
    FIG 2

    Palmitoylated Rho2 is targeted to the plasma membrane and is essential during morphogenesis but not for GTPase activity. (A) Deconvolved images of cells from strains LSM500 (GFP-Rho2-HA-CCIIS, control), LSM501 (GFP-Rho2-HA-SCIIS), LSM502 (GFP-Rho2-HA-CSIIS), and LSM503 (GFP-Rho2-HA-SSIIS) grown in YES medium and observed by fluorescence microscopy. GFP fluorescence density histograms across the longitudinal axis (dotted white lines) of representative cells in late G2 phase are shown. (B) Density gradient centrifugation in 10 to 65% sucrose of cell extracts from growing cultures of strains LSM521 (GFP-Rho2-HA-CCIIS, SPAC1B2.03c-GFP, control) and LSM522 (GFP-Rho2-HA-SCIIS, SPAC1B2.03c-GFP). Aliquots from the indicated fractions (fraction 1 is the bottom of the tube) were subjected to Western blot analysis with anti-GFP antibody to detect GFP-Rho2 and SPAC1B2.03c-GFP (endoplasmic reticulum marker) fusions, anti-Pma1 antibody (plasma membrane marker), anti-Pep12 antibody (endosomal marker), and anti-ATP6V1B2 (Vma2) antibody (vacuole marker). (C) Strain MI700 (rho2Δ) was transformed separately with plasmid pREP3X-Rho2-HA-CCIIS (control), pREP3X-Rho2-HA-SCIIS, pREP3X-Rho2-HA-CSIIS, or pREP3X-Rho2-HA-SSIIS and thereafter grown for 18 h in the absence of thiamine (−B1). Cell morphology was analyzed by fluorescence microscopy after staining of cells with calcofluor white. (D) Serially diluted cells from transformants described for panel C were spotted on EMM2 plates with (+B1) or without (−B1) 5 mM thiamine and incubated for 4 days at 28°C. (E) Cell extracts from strains expressing genomic integrated versions of rho2+ alleles described for panel C were precipitated with GST-RBD and blotted against anti-HA antibody (top). Total HA-Rho2 was estimated by Western blotting with anti-HA antibody (middle), and Pmk1-HA was detected in the same extracts as the loading control (bottom). Quantification of the ratio of GTP bound to total Rho2 is shown.

  • FIG 3
    • Open in new tab
    • Download powerpoint
    FIG 3

    In vivo palmitoylation of Rho2 is essential for signaling to the cell integrity pathway during vegetative growth and in response to stress. (A) Strains MI700 (rho2Δ), LSM400 (Rho2-HA-CCIIS; control [C]), LSM401 (Rho2-HA-SCIIS), LSM402 (Rho2-HA-CSIIS), and LSM403 (Rho2-HA-SSIIS) were grown in YES medium, and activated and total Pmk1s were detected with anti-phosho-p42/44 and anti-HA antibodies, respectively. (B) Strain MI102 (pmk1Δ) and those described for panel A were grown in YES medium, and serially diluted cells were spotted on YES plates supplemented with either 0.1 M or 0.2 M MgCl2 plus 1 μg/ml FK506 (VIC). (C) Strains described for panel A were grown as above and treated with either 0.6 M KCl or 1 μg/ml caspofungin or subjected to a hypotonic treatment. (D) Serially diluted cells of strains described for panel B were spotted on YES plates supplemented with 0.8, 1, or 1.2 μg/ml caspofungin. (E) Strain MI700 (rho2Δ, Pmk1-HA) was transformed with plasmid pREP3X-Rho2-HA-CCIIS (control), pREP3X-Rho2-HA-SCIIS, pREP3X-Rho2-HA-CSIIS, or pREP3X-Rho2-HA-SSIIS, and the corresponding transformants were grown for 20 h in the presence or absence of thiamine (B1). Both activated and total Pmk1s were detected as previously described.

  • FIG 4
    • Open in new tab
    • Download powerpoint
    FIG 4

    Artificial plasma membrane targeting bypasses the Rho2 need for palmitoylation in order to signal. (A) Deconvolved images of cells from strains LSM500 (GFP-Rho2-HA-CCIIS, control) and LSM970 (GFP-Rho2-HA-RitC). The percentage of GFP-Rho2 at the plasma membrane (PM) with respect to the whole cell is shown at the right (n ≥ 15 cells). (B) Density gradient centrifugation of cell extracts from cultures of strains LSM521 (GFP-Rho2-HA-CCIIS, SPAC1B2.03c-GFP, control) and LSM970 (GFP-Rho2-HA-RitC). Aliquots from the indicated fractions were subjected to Western blot analysis with anti-GFP and anti-Pma1 antibodies (plasma membrane marker). (C) Strains LSM400 (Rho2-HA-CCIIS, control), MI700 (rho2Δ), LSM403 (Rho2-HA-SSIIS), and LSM971 (Rho2-HA-RitC) were grown in YES medium, and activated and total Pmk1s were detected with anti-phosho-p42/44 and anti-HA antibodies, respectively. (D) Serially diluted cells of strains described for panel C were spotted on YES plates supplemented with either 0.05 M or 0.1 M MgCl2 plus 1 μg/ml FK506 (VIC) or with 0.6 or 1 μg/ml caspofungin. (E) Strains LSM400 and LSM971 were treated with either 0.6 M KCl (left) or subjected to a hypotonic treatment (right). Activated and total Pmk1s were detected as previously shown.

  • FIG 5
    • Open in new tab
    • Download powerpoint
    FIG 5

    Rho1 C-terminal polybasic sequence disturbs palmitoylation and signaling of geranylgeranylated but not farnesylated Rho2. (A) C-terminal sequences of Rho2 and Rho2-Rho1 chimeras. Rho1 C-terminal sequences are underlined, whereas amino acids derived from Rho2 terminal sequences are in bigger letters. (B) Deconvolved images of cells from strains LSM500 (GFP-Rho2-HA-CCIIS, control), LSM505 (GFP-Rho2-HA-RCILL), LSM506 (GFP-Rho2-HA-CCILL), and LSM507 (GFP-Rho2-HA-CCILS). The percentage of GFP-Rho2 at the plasma membrane with respect to the whole cell is shown at the right (n ≥ 15 cells; *, P < 0.05 in mutants compared to the control). (C) Strain MI700 (rho2Δ, Pmk1-HA) was transformed separately with plasmid pREP3X-Rho2-HA-CCIIS (control), pREP3X-Rho2-HA-RCILL, pREP3X-Rho2-HA-CCILL, or pREP3X-Rho2-HA-CCILS, and serially diluted cells from the respective cultures were spotted on EMM2 plates with (+B1) or without (−B1) 5 mM thiamine and incubated for 4 days at 28°C. (D) Strains LSM400 (Rho2-HA-CCIIS, control), LSM405 (Rho2-HA-RCILL), LSM406 (Rho2-HA-CCILL), LSM407 (Rho2-HA-CCILS), and MI700 (rho2Δ) were grown in YES medium, and both activated and total Pmk1s were detected as described for Fig. 1. (E) Strains described for panel D were grown in YES medium, and serially diluted cells were spotted on YES plates supplemented with 0.05 M or 0.1 M MgCl2 plus 1 μg/ml FK506 (VIC). (F) Strains described for panel D were either treated with 0.6 M KCl or subjected to a hypotonic treatment. (G) Rho2 palmitoylation assayed by the acyl-biotinyl switch assay in cell lysates from strains described for panel D.

  • FIG 6
    • Open in new tab
    • Download powerpoint
    FIG 6

    Rho GDI Rdi1 negatively regulates the cell integrity pathway through a Rho1-dependent mechanism. (A) Exponentially growing cultures of strains MI200 (control), MI700 (rho2Δ), LSM750 (rdi1Δ), and LSM760 (rho2Δ rdi1Δ), were grown in YES medium. Both activated and total Pmk1s were detected with anti-phospho-p44/42 and anti-HA antibodies, respectively. (B to D) Strains LSM400 (Rho2-HA-CCIIS, control) and LSM770 (Rho2-HA-CCIIS rdi1Δ) (B), LSM405 (Rho2-HA-RCILL) and LSM780 (Rho2-HA-RCILL rdi1Δ) (C), and LSM401 (Rho2-HA-SCIIS) and LSM790 (Rho2-HA-SCIIS rdi1Δ) (D) were treated with 0.6 M KCl. Aliquots were harvested at timed intervals, and activated and total Pmk1s were detected as described above.

  • FIG 7
    • Open in new tab
    • Download powerpoint
    FIG 7

    Erf2 acyltransferase is the major protein responsible for Rho2 palmitoylation in vivo. (A) Exponentially growing cultures of strains MI200 (control), LSM810 (akr1Δ), LSM820 (pfa3Δ), LSM830 (pfa5Δ), LSM840 (erf2Δ), and LSM850 (erf4Δ) were treated with 0.6 M KCl. Aliquots were harvested at timed intervals, and activated and total Pmk1s were detected with anti-phospho-p44/42 and anti-HA antibodies, respectively. (B) Strains MI200 (control) and LSM840 (erf2Δ) were subjected to a hypotonic treatment, and both activated and total Pmk1s were detected. (C) Strains MI200 (control), LSM840 (erf2Δ), and LSM860 (erf2Δ akr1Δ pfa3Δ pfa5Δ) were subjected to hypotonic treatment, and both activated and total Pmk1s were detected. (D) Deconvolved images of cells from strains LSM500 (GFP-Rho2-HA-CCIIS, control) and LSM841 (GFP-Rho2-HA-CCIIS erf2Δ). The percentage of GFP-Rho2 at the plasma membrane with respect to the whole cell is shown at the right (n = 14 cells; *, P < 0.05 in erf2Δ cells compared to the control). (E) Rho2 palmitoylation assayed by the acyl-biotinyl switch assay (upper blot) in cell lysates from strains LSM400 (Rho2-HA-CCIIS, control), LSM842 (Rho2-HA-CCIIS erf2Δ), and LSM852 (Rho2-HA-CCIIS erf4Δ). (F) Exponentially growing cultures of strains MI700 (rho2Δ), LSM401 (Rho2-SCIIS), MI200 (control), LSM840 (erf2Δ), and LSM860 (erf2Δ akr1Δ pfa3Δ pfa5Δ) were grown in YES medium, and both activated and total Pmk1s were detected as above. (G) Serially diluted cells of strains described for panel F were spotted on YES plates supplemented with 0.05 M or 0.1 M MgCl2 plus 1 μg/ml FK506 (VIC) and incubated for 3 days at 28°C.

  • FIG 8
    • Open in new tab
    • Download powerpoint
    FIG 8

    Erf2-palmitoylated Rho2 and Rho3 regulate the cell integrity MAPK pathway in an antagonistic fashion. (A) Serially diluted cells of strains MI200 (control), MI700 (rho2Δ), LSM901 (rho3Δ), and LSM902 (ras1Δ) were spotted on YES plates supplemented with 0.2 or 0.3 M MgCl2 and incubated for 3 days at 28°C. (B) Strains MI200 (control), MI700 (rho2Δ), LSM901 (rho3Δ), LSM903 (rho2Δ rho3Δ), LSM840 (erf2Δ), and LSM904 (rho2Δ erf2Δ) were grown in YES medium, and activated and total Pmk1s were detected with anti-phospho-p44/42 and anti-HA antibodies, respectively. (C) Serially diluted cells of strains described for panel B were spotted on YES plates supplemented with 0.05 M or 0.1 M MgCl2 plus 1 μg/ml FK506 (VIC) and incubated for 3 days at 28°C. (D) Erf2 palmitoylates Rho2 and Rho3 to antagonistically regulate the Pmk1 MAPK cascade (see the text for details).

Tables

  • Figures
  • Additional Files
  • TABLE 1

    S. pombe strains used in this studya

    StrainDescriptionSource or reference
    MI200h+ pmk1-HA6H:ura4+24
    MI201h− pmk1-HA6H:ura4+24
    MI700h+ rho2::kanR pmk1-HA6H:ura4+23
    PPG4549h+ GFP-rho2:kanR30
    PPG4546h+ 3HA-rho2::kanR30
    PPG49MIh+ GFP-rho2:kanR pmk1-HA6H:ura4+This work
    PPG46MIh+ 3HA-rho2::kanR pmk1-HA6H:ura4+This work
    LSM300h+ rho2-GFP-KSSTKCCIIS:leu1+ rho2::kanR pmk1-HA6H:ura4+This work
    LSM400h+ rho2-HA-KSSTKCCIIS:leu1+ rho2::kanR pmk1-HA6H:ura4+This work
    LSM401h+ rho2-HA-KSSTKSCIIS:leu1+ rho2::kanR pmk1-HA6H:ura4+This work
    LSM402h+ rho2-HA-KSSTKCSIIS:leu1+ rho2::kanR pmk1-HA6H:ura4+This work
    LSM403h+ rho2-HA-KSSTKSSIIS:leu1+ rho2::kanR pmk1-HA6H:ura4+This work
    LSM500h+ GFP-rho2-HA-KSSTKCCIIS:leu1+ rho2::kanR pmk1-HA6H:ura4+This work
    LSM501h+ GFP-rho2-HA-KSSTKSCIIS:leu1+ rho2::kanR pmk1-HA6H:ura4+This work
    LSM502h+ GFP-rho2-HA-KSSTKCSIIS:leu1+ rho2::kanR pmk1-HA6H:ura4+This work
    LSM503h+ GFP-rho2-HA-KSSTKSSIIS:leu1+ rho2::kanR pmk1-HA6H:ura4+This work
    LSM520h− SPAC1B2.03c-GFP:kanRThis work
    LSM521h+ GFP-rho2-HA-KSSTKCCIIS:leu1+ SPAC1B2.03c-GFP:kanR rho2::kanR pmk1-HA6H:ura4+This work
    LSM522h+ GFP-rho2-HA-KSSTKSCIIS:leu1+ SPAC1B2.03c-GFP:kanR rho2::kanR pmk1-HA6H:ura4+This work
    LSM404h+ rho2-HA-KSSTKCCIIL:leu1+ rho2::kanR pmk1-HA6H:ura4+This work
    LSM504h+ GFP-rho2-HA-KSSTKCCIIL:leu1+ rho2::kanR pmk1-HA6H:ura4+This work
    LSM405h+ rho2-HA-TKKKKRCILL:leu1+ rho2::kanR pmk1-HA6H:ura4+This work
    LSM406h+ rho2-HA-TKKKKCCILL:leu1+ rho2::kanR pmk1-HA6H:ura4+This work
    LSM407h+ rho2-HA-TKKKKCCILS:leu1+ rho2::kanR pmk1-HA6H:ura4+This work
    LSM505h+ GFP-rho2-HA-TKKKKRCILL:leu1+ rho2::kanR pmk1-HA6H:ura4+This work
    LSM506h+ GFP-rho2-HA-TKKKKCCILL:leu1+ rho2::kanR pmk1-HA6H:ura4+This work
    LSM507h+ GFP-rho2-HA-TKKKKCCILS:leu1+ rho2::kanR pmk1-HA6H:ura4+This work
    LSM750h− rdi1::kanR pmk1-HA6H:ura4+This work
    LSM760h+ rho2::kanR rdi1::kanR pmk1-HA6H:ura4+This work
    LSM770h+ rho2-HA-KSSTKCCIIS:leu1+ rho2::kanR rdi1::kanR pmk1-HA6H:ura4+This work
    LSM780h+ rho2-HA-TKKKKRCILL:leu1+ rho2::kanR rdi1::kanR pmk1-HA6H:ura4+This work
    LSM790h+ rho2-HA-KSSTKSCIIS:leu1+ rho2::kanR rdi1::kanR pmk1-HA6H:ura4+This work
    LSM810h− akr1::kanR pmk1-HA6H:ura4+This work
    LSM820h− pfa3::kanR pmk1-HA6H:ura4+This work
    LSM830h− pfa5::kanR pmk1-HA6H:ura4+This work
    LSM840h− erf2::kanR pmk1-HA6H:ura4+This work
    LSM850h− erf4::kanR pmk1-HA6H:ura4+This work
    LSM860h− erf4::kanR akr1::kanR pfa3::kanR pfa5::NatR pmk1-HA6H:ura4+This work
    LSM841h+ GFP-rho2-HA-KSSTKCCIIS:leu1+ rho2::kanR erf2::kanR pmk1-HA6H:ura4+This work
    LSM842h+ rho2-HA-KSSTKCCIIS:leu1+ rho2::kanR erf2::kanR pmk1-HA6H:ura4+This work
    LSM852h+ rho2-HA-KSSTKCCIIS:leu1+ rho2::kanR erf4::kanR pmk1-HA6H:ura4+This work
    LSM901h− rho3::natR pmk1-HA6H:ura4+This work
    LSM902h− ras1::kanR pmk1-HA6H:ura4+This work
    LSM903h− rho2::kanR rho3::natR pmk1-HA6H:ura4+This work
    LSM904h− erf2::kanR rho3::natR pmk1-HA6H:ura4+This work
    LSM970h+ GFP-rho2-HA-RitC:leu1+ rho2::kanR pmk1-HA6H:ura4+This work
    LSM971h+ rho2-HA-RitC:leu1+ rho2::kanR pmk1-HA6H:ura4+This work
    • ↵a All strains are ade− leu1-32 ura4D-18. Substituted amino acids within the natural C-terminal motifs of either Rho2 or Rho1 are underlined.

Additional Files

  • Figures
  • Tables
  • Supplemental material

    Files in this Data Supplement:

    • Supplemental file 1 -

      Fig. S1 (Rho2-tagged strains)

      PDF, 1.2M

    • Supplemental file 2 -

      Fig. S2 (Geranyl geranylation and signaling properties of palmitoylated Rho2)

      PDF, 1.6M

PreviousNext
Back to top
Download PDF
Citation Tools
Rho2 Palmitoylation Is Required for Plasma Membrane Localization and Proper Signaling to the Fission Yeast Cell Integrity Mitogen-Activated Protein Kinase Pathway
Laura Sánchez-Mir, Alejandro Franco, Rebeca Martín-García, Marisa Madrid, Jero Vicente-Soler, Teresa Soto, Mariano Gacto, Pilar Pérez, José Cansado
Molecular and Cellular Biology Jun 2014, 34 (14) 2745-2759; DOI: 10.1128/MCB.01515-13

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Molecular and Cellular Biology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Rho2 Palmitoylation Is Required for Plasma Membrane Localization and Proper Signaling to the Fission Yeast Cell Integrity Mitogen-Activated Protein Kinase Pathway
(Your Name) has forwarded a page to you from Molecular and Cellular Biology
(Your Name) thought you would be interested in this article in Molecular and Cellular Biology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Rho2 Palmitoylation Is Required for Plasma Membrane Localization and Proper Signaling to the Fission Yeast Cell Integrity Mitogen-Activated Protein Kinase Pathway
Laura Sánchez-Mir, Alejandro Franco, Rebeca Martín-García, Marisa Madrid, Jero Vicente-Soler, Teresa Soto, Mariano Gacto, Pilar Pérez, José Cansado
Molecular and Cellular Biology Jun 2014, 34 (14) 2745-2759; DOI: 10.1128/MCB.01515-13
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About MCB
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #MCBJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0270-7306; Online ISSN: 1098-5549